Search
for
Sort by
Research 91–120 of 1000+
- Hair Supplements
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Components of Severity in Alopecia Areata
- INDIVIDUAL ARTICLE: Etiology, Treatment Challenges, and the Role of Scalp and Haircare in Managing Dandruff
- Blood Pressure Monitoring for Minoxidil Therapy in Alopecia Patients
- Alopecia areata-like presentations with mogamulizumab therapy
- Emerging medications
- Is There a Role for Radiofrequency Devices in Hair?
- Patient satisfaction and adverse effects following the use of topical hair fiber fillers
- 27637 Strategies to minimize pain during platelet-rich plasma scalp injections
- Effective strategies to reduce pain during platelet-rich plasma scalp injections: A randomized split-scalp study
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Monitoring Response to Platelet-Rich Plasma in Patients with Alopecia Areata with Optical Coherence Tomography: A Case Series
- Can we halt male androgenetic alopecia progression without antiandrogenic drugs?
- The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review
- Does Complement Have a Role in the Pathogenesis of Alopecia Areata?
- Beyond the Follicle: Exploring Psychiatric Comorbidities in Androgenetic Alopecia
- Laboratory Workup and Histopathology
- Baricitinib Provides Sustained, Long-Term Efficacy With Consistent Safety for Up to 5 Years of Treatment in Adults With Severe Alopecia Areata: Final Results From BRAVE-AA1 and BRAVE-AA2
- 62339 Improvement in anxiety and depression in adult patients with severe alopecia areata treated with deuruxolitinib: Pooled data from the THRIVE-AA1 and THRIVE-AA2 Phase 3 trials
- 60058 Change in patient-reported hair satisfaction during deuruxolitinib treatment of severe alopecia areata: Pooled data from the Phase 3 THRIVE-AA1 and THRIVE-AA2 trials
- 0447 Minoxidil for onychodystrophy: Can this hair loss remedy be a nail growth remedy?
- Patient satisfaction with hair regrowth in a study of ritlecitinib: a plain language summary
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- INDIVIDUAL ARTICLE: Insights on the Impact of Scalp Barrier Condition on Hair Health
- Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Demographics and Disease Characteristics of Patients with Alopecia Areata with Comorbid Atopic Dermatitis, Vitiligo or Anxiety/Depression: TARGET-DERM AA
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA